Bassett Healthcare

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Bassett Healthcare sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).

16 total trials 1 currently recruiting 12 completed later-stage tilt top decile by trial count

Bassett Healthcare: 16 sponsored US clinical trials, 1 recruiting.

Bassett Healthcare sponsors 16 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 12 completed. 5 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Covid19 Immunology, with 1 trials.

Top-decile sponsor footprint

Bassett Healthcare ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 54/100

12 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

16 total, page 1 of 1

RECRUITING

Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

NCT04245683

NOT YET RECRUITING Phase 4

The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)

NCT07556107

COMPLETED

The COVID-19 PUI Reality Check (CPRC) Study

NCT04474288

TERMINATED Phase 2

COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19

NCT04328012

COMPLETED Phase 2

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)

NCT04327791

COMPLETED Phase 4

Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery

NCT04180943

COMPLETED

ICU Liberation: Does Enhanced Patient Mobilization Improve Outcomes?

NCT03329924

COMPLETED

Podocan and Wnt Pathway in the Development of Aortopathy in Bicuspid Valve Disease

NCT02806310

COMPLETED

Podocan and Wnt Pathway in Left Ventricular Remodeling of Aortic Stenosis

NCT02624934

COMPLETED Phase 4

Impact of Topical Pharyngeal Anesthetics on Discharge of the Patients When Used in Conjunction With Propofol Sedation in Routine EGD's

NCT02507440

COMPLETED NA

Neck Grasp as a Predictor of Sleep Apnea

NCT02474823

TERMINATED NA

Locked Versus Unlocked Set Screws in Intramedullary Fixation of Intertrochanteric Fractures

NCT02345369

COMPLETED Phase 4

Duration of Immune Response to Influenza Vaccination in Patients With RA

NCT02311855

COMPLETED NA

Chest Pain Perception and Capsaicin Sensitivity in Patients With Acute Cardiac Ischemia

NCT02346916

COMPLETED NA

Chest Pain Perception and Capsaicin Sensitivity

NCT02346903

COMPLETED Phase 4

Intranasal Midazolam in Children as a Pre-Operative Sedative

NCT02314546

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 4 5

Where Bassett Healthcare enrollment is open (later-stage tilt)

1 recruiting of 16 indexed (6% open); 12 completed (75%).

Phase mix: 5 late (III/IV) vs 2 early (I/II) (later-stage heavy).

Top condition: Covid19 Immunology (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Bassett Healthcare: open-pipeline peers nationwide

Peers matched on 16 registered trials and 6% open enrollment, not the therapeutic-area sidebar.

Bassett Healthcare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1020304050 0%5%10%15% Total trials Recruiting share Bassett HealthcareAccelerated Community Oncology Research NetworkAltimmuneAmerican UniversityAnthera PharmaceuticalsAlbert Einstein Healthcare NetworkDynavax Technologies CorporationEast Tennessee State UniversityMonell Chemical Senses Center
Bassett Healthcare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Bassett Healthcare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 16 trials (± recruiting share)

Sponsors near 6% open enrollment (± trial volume)

What to do with this Bassett Healthcare page

16 registered trials is a research-attention snapshot, not an endorsement of Bassett Healthcare or any single study.

  • 1 of Bassett Healthcare's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Covid19 Immunology is the condition Bassett Healthcare studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Covid19 Immunology trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Bassett Healthcare pipeline card: 16 registered trials from official public datasets.Report a data error.